You are here

drug pricing

Eli Lilly settles insulin suit for $13.5 million, agrees to keep price cap

Eli Lilly settles insulin suit for $13.5 million, agrees to keep price cap

Washington Post, DC

Flag link:

Johnson & Johnson cites rebates and discounts for drug price increases

Johnson & Johnson cites rebates and discounts for drug price increases

Fierce Pharma

Flag link:

Medicaid plans to audit the prices of costliest drugs

Medicaid plans to audit the prices of costliest drugs

ABC News

Flag link:

House lawmakers, PBM lobby spar over committee hearing

House lawmakers, PBM lobby spar over committee hearing

BioPharma Dive

Flag link:

This panel will decide whose medicine to make affordable. Its choice will be tricky.

This panel will decide whose medicine to make affordable. Its choice will be tricky.

Medical Marketing and Media

Flag link:

After IRA, Minnesota's drug affordability proposal draws PhRMA's ire

After IRA, Minnesota's drug affordability proposal draws PhRMA's ire

Fierce Pharma

Inflation Reduction Act

Flag link:

Pharma, patient advocates clash over Inflation Reduction Act

Pharma, patient advocates clash over Inflation Reduction Act

Clinical Trials Arena

Inflation Reduction Act

patient advocacy groups

Flag link:

Pfizer CEO Bourla slams Medicare IRA measure as 'negotiation with a gun to your head'

Pfizer CEO Bourla slams Medicare IRA measure as 'negotiation with a gun to your head'

Fierce Pharma

Inflation Reduction Act

Flag link:

JAMA: Leqembi could cost Medicare up to $5B per year

JAMA: Leqembi could cost Medicare up to $5B per year

Medical Marketing and Media

Alzheimer's disease

Flag link:

Senate health committee seeks to rein in drug prices with four new bills

Senate health committee seeks to rein in drug prices with four new bills

BioSpace

Flag link:

Gout Disease Control Suffered After FDA-Driven Price Hike: Study

Gout Disease Control Suffered After FDA-Driven Price Hike: Study

BioSpace

Flag link:

What you need to know about pharma, PBM execs testifying on insulin prices

What you need to know about pharma, PBM execs testifying on insulin prices

Medical Marketing and Media

Flag link:

US Senate kicks off fresh round of drug pricing control legislation

US Senate kicks off fresh round of drug pricing control legislation

BioSpace

Flag link:

Pharma is clearly not done fighting drug-pricing reforms

Pharma is clearly not done fighting drug-pricing reforms

Medical Marketing and Media

Inflation Reduction Act

Flag link:

Pharma Decries Drug Selection Plans in Medicare Pricing Policy

Pharma Decries Drug Selection Plans in Medicare Pricing Policy

RAPS.org

Inflation Reduction Act

Flag link:

The Inflation Reduction Act: 10 Predictions About Market Access and Drug Channels

The Inflation Reduction Act: 10 Predictions About Market Access and Drug Channels

Drug Channels

Inflation Reduction Act

Medicare Part D

Flag link:

Price cuts lead to feel-good effects for pharma industry

Price cuts lead to feel-good effects for pharma industry

Medical Marketing and Media

pharma industry

Flag link:

Bernie Sanders weighs Senate hearing for largest insulin makers

Bernie Sanders weighs Senate hearing for largest insulin makers

Seeking Alpha

Flag link:

Is the pharma industry particularly vulnerable to inflation?

Is the pharma industry particularly vulnerable to inflation?

Pharmaphorum

Flag link:

Four Trends That Will Pop the $250 Billion Gross-to-Net Bubble—and Transform PBMs, Market Access, and Benefit Design

Four Trends That Will Pop the $250 Billion Gross-to-Net Bubble—and Transform PBMs, Market Access, and Benefit Design

Drug Channels

Flag link:

Pages